Qube Research & Technologies (QRT)
EVH icon

Qube Research & Technologies (QRT)’s Evolent Health EVH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
216,175
-341,655
-61% -$1.31M ﹤0.01% 2350
2026
Q1 		$1.27M Buy
557,830
+383,802
+221% +$1.22M ﹤0.01% 2386
2025
Q4 		$696K Buy
+174,028
New +$967K ﹤0.01% 2704
2024
Q3 		– Sell
-638,164
Closed -$12.2M – 3525
2024
Q2 		$12.2M Buy
638,164
+532,474
+504% +$13.6M 0.02% 823
2024
Q1 		$3.47M Buy
105,690
+91,123
+626% +$2.91M 0.01% 1432
2023
Q4 		$481K Buy
+14,567
New +$412K ﹤0.01% 2310
2022
Q4 		– Sell
-81,883
Closed -$2.94M – 2612
2022
Q3 		$2.94M Buy
+81,883
New +$2.88M 0.02% 787
2022
Q2 		– Sell
-33,974
Closed -$1.1M – 2661
2022
Q1 		$1.1M Buy
33,974
+15,840
+87% +$415K 0.01% 1128
2021
Q4 		$502K Buy
+18,134
New +$520K ﹤0.01% 1566

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Evolent Health (EVH) stake by 61% in Q2 2026, selling an estimated $1.31M and leaving 216,175 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Qube Research & Technologies (QRT) first reported a position in EVH in Q4 2021 and has held it in 9 quarters since. The position peaked at $12.2M in Q2 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 216,175 shares of Evolent Health worth $1.17M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 341,655 Evolent Health shares in Q2 2026, an estimated $1.31M.
  • Evolent Health made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2350 holding.
  • Qube Research & Technologies (QRT) first reported a position in Evolent Health in Q4 2021 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Evolent Health position peaked at $12.2M in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.